PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.52%
Revenue growth above 1.5x 6617.T's 10.77%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
3.07%
Positive gross profit growth while 6617.T is negative. John Neff would see a clear operational edge over the competitor.
-23.79%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-11.85%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-39.97%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-40.07%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-40.07%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.94%
10Y revenue/share CAGR under 50% of 6617.T's 23.06%. Michael Burry would suspect a lasting competitive disadvantage.
70.25%
5Y revenue/share CAGR above 1.5x 6617.T's 2.64%. David Dodd would look for consistent product or market expansions fueling outperformance.
51.85%
3Y revenue/share CAGR above 1.5x 6617.T's 12.68%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.55%
Negative 10Y net income/share CAGR while 6617.T is at 183.84%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-95.82%
Negative 5Y net income/share CAGR while 6617.T is 217.72%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
109.89%
3Y net income/share CAGR 50-75% of 6617.T's 205.10%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
284.19%
10Y equity/share CAGR above 1.5x 6617.T's 14.50%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
35.04%
5Y equity/share CAGR above 1.5x 6617.T's 12.95%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
26.04%
3Y equity/share CAGR above 1.5x 6617.T's 13.35%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.25%
AR growth is negative/stable vs. 6617.T's 8.92%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
7.64%
Inventory growth well above 6617.T's 9.29%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.58%
Asset growth at 50-75% of 6617.T's 2.17%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-0.22%
We have a declining book value while 6617.T shows 1.41%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.58%
Debt growth of 4.58% while 6617.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
1.28%
R&D dropping or stable vs. 6617.T's 8.74%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-17.74%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.